Genmab A/S
Utility Patents
Last updated:
List of all Genmab A/S patents 25 in total
| Status | Patent |
|---|---|
Grant | Utility: Humanized or chimeric CD3 antibodies Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Antibodies Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Antibodies against human CD38 Filling date: 6 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Antibodies Filling date: 6 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Monoclonal antibodies against HER2 Filling date: 6 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Methods of producing multispecific antibodies against CD40 and CD137 Filling date: 6 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Multispecific antibodies against CD40 and CD137 Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Monoclonal antibodies against HER2 Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Antibodies Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Binding agents binding to PD-L1 and CD137 and use thereof Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Agonistic tumor necrosis factor (TNF) receptor binding agents Filling date: 6 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Bispecific antibodies and methods for production thereof Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Rodent bispecific heterodimeric proteins Filling date: 6 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Monoclonal antibodies against HER2 epitope Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Stable IgG4 antibodies Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Human monoclonal antibodies against CD25 Filling date: 6 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Utility: Lyophilized anti-tissue factor antibody-drug conjugates Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Heterodimeric antibody Fc-containing proteins and methods for production thereof Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Inert format Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Bispecific antibodies against CD3 and CD20 Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 24 Dec 2019 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Humanized or chimeric CD3 antibodies Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Showing 1 to 25 of 25 patents.